Bile Acid-Activated Nuclear Receptor FXR Suppresses Apolipoprotein A-I Transcription via a Negative FXR Response Element

Journal of Clinical Investigation - United States
doi 10.1172/jci200214505
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

SREBF2-Embedded Mir33 Links the Nuclear Bile Acid Receptor FXR to Cholesterol and Lipoprotein Metabolism: Figure.

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2015English

Bile Acids Lower Triglyceride Levels via a Pathway Involving FXR, SHP, and SREBP-1c

Journal of Clinical Investigation
Medicine
2004English

New Horizons in the Regulation of Bile Acid and Lipid Homeostasis: Critical Role of the Nuclear Receptor FXR as an Intracellular Bile Acid Sensor

Gut
Gastroenterology
2001English

FXR Induces SOCS3 and Suppresses Hepatocellular Carcinoma

Oncotarget
Oncology
2015English

Role of Bile Acid–Regulated Nuclear Receptor FXR and G Protein–Coupled Receptor TGR5 in Regulation of Cardiorenal Syndrome (Cardiovascular Disease and Chronic Kidney Disease)

Hypertension
Internal Medicine
2016English

Transcriptional Integration of Metabolism by the Nuclear Sterol-Activated Receptors LXR and FXR

Nature Reviews Molecular Cell Biology
Cell BiologyMolecular Biology
2012English

Postprandial FGF19-induced Phosphorylation by SRC Is Critical for FXR Function in Bile Acid Homeostasis

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2018English

Bile Acids Promote Gastric Intestinal Metaplasia by Upregulating CDX2 and MUC2 Expression via the FXR/NF-κB Signalling Pathway

International Journal of Oncology
Cancer ResearchOncology
2019English

Bile Acids Decrease Hepatic Paraoxonase 1 Expression and Plasma High-Density Lipoprotein Levels via FXR-Mediated Signaling of FGFR4

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy